Integrated in silico investigation of an androstendiol derivative (monoxetanol) as a potential anti-prostate cancer agent: insights from molecular docking, MD simulations, MM/PBSA, ADMET, and DFT analyses.

Saved in:
Bibliographic Details
Title: Integrated in silico investigation of an androstendiol derivative (monoxetanol) as a potential anti-prostate cancer agent: insights from molecular docking, MD simulations, MM/PBSA, ADMET, and DFT analyses.
Authors: Bekkar Y; Laboratory of Valorisation and Technology of Saharian Resources (VTRS), Department of Process Engineering and Petrochemistry, Faculty of Technology, University of El Oued, 39000 El Oued, Algeria., Elhafnaoui L; Laboratory of Valorisation and Technology of Saharian Resources (VTRS), Department of Process Engineering and Petrochemistry, Faculty of Technology, University of El Oued, 39000 El Oued, Algeria., Al-Masoudi NA; Department of Chemistry, College of Science, University of Basrah, Basrah, Iraq.; Present Address: Constance, Germany., Abdul-Rida NA; Department of Chemistry, College of Science, University of Qadisiyah, Diwanyiah, Iraq., Al-Masoudi WA; Department of Physiology and Chemistry, College of Veterinary, University of Basrah, Basrah, Iraq., Mahdi AM; Najaf Education Directorate, Ministry of Education, Najaf City, Iraq.
Source: In silico pharmacology [In Silico Pharmacol] 2026 May 07; Vol. 14 (2), pp. 134. Date of Electronic Publication: 2026 May 07 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag, GmbH Country of Publication: Germany NLM ID: 101623954 Publication Model: eCollection Cited Medium: Print ISSN: 2193-9616 (Print) Linking ISSN: 21939616 NLM ISO Abbreviation: In Silico Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42109568
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Integrated in silico investigation of an androstendiol derivative (monoxetanol) as a potential anti-prostate cancer agent: insights from molecular docking, MD simulations, MM/PBSA, ADMET, and DFT analyses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bekkar+Y%22">Bekkar Y</searchLink>; Laboratory of Valorisation and Technology of Saharian Resources (VTRS), Department of Process Engineering and Petrochemistry, Faculty of Technology, University of El Oued, 39000 El Oued, Algeria.<br /><searchLink fieldCode="AU" term="%22Elhafnaoui+L%22">Elhafnaoui L</searchLink>; Laboratory of Valorisation and Technology of Saharian Resources (VTRS), Department of Process Engineering and Petrochemistry, Faculty of Technology, University of El Oued, 39000 El Oued, Algeria.<br /><searchLink fieldCode="AU" term="%22Al-Masoudi+NA%22">Al-Masoudi NA</searchLink>; Department of Chemistry, College of Science, University of Basrah, Basrah, Iraq.; Present Address: Constance, Germany.<br /><searchLink fieldCode="AU" term="%22Abdul-Rida+NA%22">Abdul-Rida NA</searchLink>; Department of Chemistry, College of Science, University of Qadisiyah, Diwanyiah, Iraq.<br /><searchLink fieldCode="AU" term="%22Al-Masoudi+WA%22">Al-Masoudi WA</searchLink>; Department of Physiology and Chemistry, College of Veterinary, University of Basrah, Basrah, Iraq.<br /><searchLink fieldCode="AU" term="%22Mahdi+AM%22">Mahdi AM</searchLink>; Najaf Education Directorate, Ministry of Education, Najaf City, Iraq.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101623954%22">In silico pharmacology</searchLink> [In Silico Pharmacol] 2026 May 07; Vol. 14 (2), pp. 134. <i>Date of Electronic Publication: </i>2026 May 07 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%2C+GmbH%22">Springer-Verlag, GmbH </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101623954 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2193-9616 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221939616%22">21939616 </searchLink><i>NLM ISO Abbreviation: </i>In Silico Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42109568
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40203-026-00626-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 134
    Titles:
      – TitleFull: Integrated in silico investigation of an androstendiol derivative (monoxetanol) as a potential anti-prostate cancer agent: insights from molecular docking, MD simulations, MM/PBSA, ADMET, and DFT analyses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bekkar Y
      – PersonEntity:
          Name:
            NameFull: Elhafnaoui L
      – PersonEntity:
          Name:
            NameFull: Al-Masoudi NA
      – PersonEntity:
          Name:
            NameFull: Abdul-Rida NA
      – PersonEntity:
          Name:
            NameFull: Al-Masoudi WA
      – PersonEntity:
          Name:
            NameFull: Mahdi AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 05
              Text: 2026 May 07
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2193-9616
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: In silico pharmacology
              Type: main
ResultId 1